Payment overview · 2025
General Payments
$141.90
6 reported records · 5 companies
Healthcare provider profile · identity verified
Daniel Ferguson, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SLIPPERY ROCK, PA · NPI 1871570747
Verified facts
What the public records show
CMS Open Payments records show Daniel Ferguson, M.D. received $141.90 in general payments during 2025 across 6 reported records.
Axsome Therapeutics, Inc. accounted for 33.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 80 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Nurtec Odt by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $47.26 | 33.3% | 2 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $29.97 | 21.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $25.00 | 17.6% | 1 | 2025 |
| Tonix Medicines, Inc. | Unresolved — no canonical attribution shown | $24.33 | 17.1% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $15.34 | 10.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $141.90 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $29.97 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $28.80 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $25.00 | 1 | 2025 |
Source payment records
|
|||||
| TONMYA Normalized: tonmya |
Drug | Tonix Medicines, Inc. | $24.33 | 1 | 2025 |
Source payment records
|
|||||
| Symbravo Normalized: symbravo |
Drug | Axsome Therapeutics, Inc. | $18.46 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $15.34 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $15.34 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $15.34 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
80 | 19 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Omeprazole | Omeprazole | 447 | 74 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 336 | 109 |
| Atorvastatin Calcium | Atorvastatin Calcium | 304 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 283 | 39 |
| Levothyroxine Sodium | Levothyroxine Sodium | 282 | 58 |
| Lisinopril | Lisinopril | 266 | 75 |
| Metformin Hcl | Metformin Hcl | 263 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 261 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 242 | 55 |
| Sertraline Hcl | Sertraline Hcl | 220 | 44 |
| Furosemide | Furosemide | 215 | 62 |
| Gabapentin | Gabapentin | 207 | 46 |
| Losartan Potassium | Losartan Potassium | 198 | 49 |
| Amlodipine Besylate | Amlodipine Besylate | 194 | 53 |
| Levetiracetam | Levetiracetam | 181 | 15 |
| Simvastatin | Simvastatin | 174 | 44 |
| Meloxicam | Meloxicam | 172 | 38 |
| Lactulose | Lactulose | 142 | 15 |
| Clonazepam | Clonazepam | 127 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 118 | 47 |
| Valsartan | Valsartan | 114 | 36 |
| Ozempic | Semaglutide | 112 | 20 |
| Baclofen | Baclofen | 111 | suppressed |
| Famotidine | Famotidine | 110 | 21 |
| Lamotrigine | Lamotrigine | 110 | suppressed |
| Atenolol | Atenolol | 104 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 99 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 94 | 21 |
| Potassium Chloride | Potassium Chloride | 90 | 20 |
| Gentamicin Sulfate | Gentamicin Sulfate | 89 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 86 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 85 | 30 |
| Aripiprazole | Aripiprazole | 84 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 83 | 19 |
| Eliquis | Apixaban | 80 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | 25 |
| Ezetimibe | Ezetimibe | 70 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 67 | 13 |
| Trulicity | Dulaglutide | 65 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 62 | suppressed |
| Carvedilol | Carvedilol | 61 | 16 |
| Pregabalin | Pregabalin | 61 | suppressed |
| Risperidone | Risperidone | 61 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 61 | 15 |
| Allopurinol | Allopurinol | 59 | 20 |
| Divalproex Sodium | Divalproex Sodium | 59 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 58 | 18 |
| Warfarin Sodium | Warfarin Sodium | 58 | 11 |
| Lorazepam | Lorazepam | 55 | 25 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 54 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 53 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 52 | 17 |
| Carbamazepine | Carbamazepine | 51 | suppressed |
| Olanzapine | Olanzapine | 50 | suppressed |
| Glipizide | Glipizide | 46 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 45 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 43 | 13 |
| Diazepam | Diazepam | 42 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 42 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Synthroid | Levothyroxine Sodium | 39 | suppressed |
| Linzess | Linaclotide | 37 | suppressed |
| Spironolactone | Spironolactone | 37 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 37 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 34 | 12 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 34 | suppressed |
| Celecoxib | Celecoxib | 34 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 34 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Prolia | Denosumab | 33 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 32 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 32 | 14 |
| Lithium Carbonate | Lithium Carbonate | 32 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 31 | suppressed |
| Glipizide Er | Glipizide | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Prednisone | Prednisone | 31 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 30 | 27 |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 30 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | suppressed |
| Irbesartan | Irbesartan | 30 | suppressed |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Bumetanide | Bumetanide | 29 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Fluconazole | Fluconazole | 29 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 28 | 13 |
| Nystatin | Nystatin | 28 | 13 |
| Budesonide | Budesonide | 26 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 26 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 25 | suppressed |
| Phenobarbital | Phenobarbital | 25 | suppressed |
| Primidone | Primidone | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 24 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Jantoven | Warfarin Sodium | 23 | suppressed |
| Sucralfate | Sucralfate | 23 | suppressed |
| Alprazolam | Alprazolam | 22 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 22 | suppressed |
| Glimepiride | Glimepiride | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Minoxidil | Minoxidil | 21 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Jardiance | Empagliflozin | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Latanoprost | Latanoprost | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Loperamide | Loperamide Hcl | 17 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 12 |
| Epinephrine | Epinephrine | 16 | 12 |
| Scopolamine | Scopolamine | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 15 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Ssd | Silver Sulfadiazine | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Budesonide Dr | Budesonide | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Finasteride | Finasteride | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 13 | suppressed |
| Clobazam | Clobazam | 12 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | 11 |
| Bydureon Bcise | Exenatide Microspheres | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Entecavir | Entecavir | 11 | suppressed |
| Multaq | Dronedarone Hcl | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $141.90 · 6 records | Axsome Therapeutics, Inc. | ABRYSVO, Auvelity, COMIRNATY, Cologuard Collection Kit, PREVNAR 20, Symbravo, TONMYA, Veozah | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error